1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
7Gaede P, Vedel P, Parring HH, et al. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lallcet1999, 353: 617-620.
8Ilkova H, Glaser B, Tunckale A, et al. Induction of longterm glycemic control in newly diagnosed Type 2 Diabetic patients by transient intensive insulin treatment. Diabetes care 1997,20:1353-1356.
9Abraira C, Colwell J, NuUal F, et al. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type Ⅱ Oiabetes (VACSDM) Groop. Cardiovascular events alld conelates in ale Veterans Affairs diabetes feasibility trial. Arch Intern Med 1997, 157: 181-188.
10UK Prospective Diabetes Study Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients widl type 2 diabetes (UKPDS33).Lancet 1998,352: S37-S53..
